drugset / Trial / NCT02157935
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Comparing the efficacy of Symbicort® pMDI and Formoterol Turbuhaler in reducing exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2014-06-27
- Primary completion
- 2016-02-08
- Completion
- 2016-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 160 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 4.5 ug | Inhaled |